>MRX Solodyn – It appears that we now know of another filler: Mylan<
MRX will almost certainly settle, IMO. In these kinds of cases, the branded company either litigates all challenges or settles all challenges—rarely does it make sense to mix and match.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”